Australia TGA ARTG recordClinical Chemistry IVDs
Australia TGA ARTG Registered Device · Biomerieux Australia Pty Ltd · Biomerieux SA · Class I · Started June 20, 2022
Good Name: Biomerieux Australia Pty Ltd - Clinical Chemistry IVDs
- Risk Class
- Class I
- Product Type
- IVD
- ARTG Category
- IVD-Export
- Start Date
- June 20, 2022
- Effective Date
- June 20, 2022
- Name
- Biomerieux SA
- Country
- France
- Address
- 376 Chemin de l'Orme, Marcy, L Etoile, 69280
IVDs that are intended to be used for the qualitative and/or quantitative determination of troponin and its various forms in a clinical specimen.
Access comprehensive regulatory information for Clinical Chemistry IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Biomerieux Australia Pty Ltd, manufactured by Biomerieux SA in France. The device registration started on June 20, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.